API
NVO

Advisor Partners II’s Novo Nordisk NVO Stock Holding History

Advisor Partners II’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$9.83M Buy
108,039
+18,299
+20% +$1.61M 0.39% 36
2023
Q2 		$7.26M Buy
89,740
+10,792
+14% +$882K 0.34% 50
2023
Q1 		$6.28M Buy
78,948
+8,062
+11% +$572K 0.35% 54
2022
Q4 		$4.8M Buy
70,886
+10,024
+16% +$588K 0.3% 67
2022
Q3 		$3.03M Buy
+60,862
New +$3.26M 0.23% 89

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Advisor Partners II's NVO Position: Q3 2023 in Review

Advisor Partners II increased its Novo Nordisk (NVO) stake by 20% in Q3 2023, buying an estimated $1.61M and bringing the position to 108,039 shares worth $9.83M. The position accounts for 0.39% of the portfolio, ranked #36.

Advisor Partners II first reported a position in NVO in Q3 2022 and has held it in 5 quarters since. 1,307 funds tracked by Wall St. Rank hold NVO as of Q3 2023.

  • Advisor Partners II held 108,039 shares of Novo Nordisk worth $9.83M as of Q3 2023.
  • Advisor Partners II bought 18,299 Novo Nordisk shares in Q3 2023, an estimated $1.61M.
  • Novo Nordisk made up 0.39% of Advisor Partners II's portfolio in Q3 2023, its #36 holding.
  • Advisor Partners II first reported a position in Novo Nordisk in Q3 2022 and has held it in 5 quarters since.
  • 1,307 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2023.

Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.